A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
France- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
5 Avenue Marechal Foch, Bp 824, 29609 Brest, France
Centre Hospitalier Regional Et Universitaire De Brest in Brest, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Gastric cancer, Sjogren's syndrome, Oesophageal adenocarcinoma, and other specialisations. This site conducts important research.
At Centre Hospitalier Regional Et Universitaire De Brest, clinical research in oncology is focused on improving care for people with Triple Negative Breast Cancer, especially those with residual disease after initial treatment. The studies are designed to better understand whether adding or adjusting treatment after surgery can improve outcomes for patients with this aggressive cancer type.
This work reflects a strong focus on cancer treatment effectiveness and post-operative care within the hospital’s Institut de cancérologie et d'hématologie.
Clinical trials currently enrolling participants at this site.
FranceLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
FranceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
FranceA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
FranceA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
FranceLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
France
FranceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.